St George’s Medical School, one of London’s United Hospitals, has been providing formal training for doctors since 1733. Approximately 3,000 medical students are currently enrolled in courses taught on the campus, which adjoins St George’s hospital in Tooting, south west London. Scientific research at St George’s has expanded over recent years to encompass a broad spectrum of interests from novel microbicides and vaccine candidates through to the study of early human development.
Research interests on the combined Medical School and Hospital site are extremely wide-ranging, encompassing a spectrum from leading-edge fundamental investigations to applied clinical and Health Services research. The research of most relevance to the ATP consortium is that conducted at the Division of Cellular and Molecular Medicine CMM, which is addressing licensing and freedom-to-operate issues so that plant produced pharmaceuticals licensed out by SGUL will benefit impoverished populations with neglected health needs. A new vaccine institute was opened in 1998, building on a heritage that goes back to Edward Jenner, a student of the school and the man who invented vaccination. The institution is extremely active in infectious diseases research and has an especially high reputation in the science and clinical practice associated with the three major infectious diseases: HIV, TB and malaria. The Molecular Immunology Group within the Division of Cellular and Molecular Medicine CMM is devoted to developing novel and innovative approaches for vaccine design and delivery, including transgenic plant technology. It has also conducted studies on the extent of academic involvement in overall licensing activity for the development of pharmaceuticals. The department addresses all aspects of pharmaceutical access from management of IP to the efficient management of clinical trials.
Partner(s) at this institution: